Plain-English translation of NCT06968065 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether a combination of two ultrasound-guided nerve blocks—called serratus anterior plane (SAP) and serratus-intercostal interfascial plane (SIP) blocks—can reduce pain better than traditional numbing injections directly into the surgical wound after minimally invasive heart surgery. Both approaches use the same numbing medication (bupivacaine) but deliver it to different areas. The study will track pain levels, how much pain medication you need, and any side effects over the first three days after surgery.
Minimally invasive heart surgery causes less damage to the body than traditional open surgery, but patients still experience significant postoperative pain. This trial exists to find the most effective way to manage that pain and help patients recover more comfortably.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will be randomly assigned to receive either the combination nerve blocks or the traditional wound infiltration during your heart surgery (after surgery but before you wake up). After surgery, the research team will ask you to rate your pain at regular intervals over the next 72 hours and will record how much pain medication you use and any side effects you experience. You will have follow-up visits or assessments at scheduled times to monitor your recovery and pain levels.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
Turkey (Türkiye)